Aaron I. Davis
Director, Odonate Therapeutics, Inc.
Companies
- iTeos Therapeutics, Inc.Board member Jul 23, 2020 to now1
- Rain Oncology Inc.Board member Apr 22, 2021 to Jan 26, 20242
- Mirati Therapeutics, Inc.Board member Dec 10, 2018 to Jan 23, 20243
- Tango Therapeutics (United States)Board member Sep 3, 2020 to Oct 11, 20234
- Odonate Therapeutics, Inc.Board member Dec 6, 2017 to Nov 19, 20215
- Tango Therapeutics (United States)Chief executive officer Sep 3, 2020 to Sep 3, 20204
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tango Therapeutics (United States) TNGX15,187,092 shares6$360.5M at $23.74Oct 17, 2023
- Mirati Therapeutics, Inc.0 shares7Jan 23, 2024
- Odonate Therapeutics, Inc.5,052,842 shares8Nov 19, 2021
- Rain Oncology Inc.2,147,212 shares9Jan 26, 2024
- iTeos Therapeutics, Inc.5,100,973 shares10May 10, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- May 10, 2024Granted 1,142,857 shares at $17.50 of iTeos Therapeutics, Inc.10
- Jan 26, 2024U 79,726 shares of Rain Oncology Inc.9
- Jan 23, 2024Returned to company 6,808 shares of Mirati Therapeutics, Inc.7
- Jan 23, 2024Returned to company 4,444 shares of Mirati Therapeutics, Inc.7
- Jan 23, 2024Returned to company 43,073 shares of Mirati Therapeutics, Inc.7
- Dec 29, 2023Granted 6,808 shares at $58.75 of Mirati Therapeutics, Inc.11
- Oct 16, 2023Bought 500,000 shares at $6.84 of Tango Therapeutics (United States)6
- Oct 13, 2023Bought 750,000 shares at $7.07 of Tango Therapeutics (United States)6
- Aug 23, 2023Sold 219,638 shares at $16.87 of iTeos Therapeutics, Inc.12
- Aug 23, 2023Sold 95,516 shares at $15.63 of iTeos Therapeutics, Inc.12
- Aug 23, 2023Sold 34,846 shares at $14.19 of iTeos Therapeutics, Inc.12
- Aug 11, 2023Granted 475,000 shares at $5.15 of Tango Therapeutics (United States)13
- Jun 6, 2023Granted 5,000 shares of Tango Therapeutics (United States)14
- Feb 10, 2023Sold 65,568 shares at $13.40 of Tyra Biosciences, Inc.15
- Feb 9, 2023Sold 200,000 shares at $13.10 of Tyra Biosciences, Inc.15
- Jan 20, 2023Granted 4,444 shares of Mirati Therapeutics, Inc.16
- Nov 4, 2022Bought 972,212 shares at $5.83 of Rain Oncology Inc.17
- May 11, 2022Sold 337,109 shares at $18.25 of iTeos Therapeutics, Inc.18
- May 11, 2022Sold 891 shares at $17.53 of iTeos Therapeutics, Inc.18
- May 10, 2022Sold 4,850 shares at $24.77 of iTeos Therapeutics, Inc.18
- May 10, 2022Sold 95,150 shares at $25.18 of iTeos Therapeutics, Inc.18
- May 9, 2022Sold 200,000 shares at $23.47 of iTeos Therapeutics, Inc.18
- May 9, 2022Sold 25,000 shares at $22.91 of iTeos Therapeutics, Inc.18
- May 2, 2022Sold 92,700 shares at $27.53 of iTeos Therapeutics, Inc.19
- May 2, 2022Sold 7,300 shares at $26.91 of iTeos Therapeutics, Inc.19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARRain Oncology Inc., Board member
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jan 3, 2024
- 12SEC EDGARForm 4 filed Aug 25, 2023
- 13SEC EDGARForm 4 filed Oct 11, 2023
- 14SEC EDGARForm 4 filed Jun 8, 2023
- 15SEC EDGARForm 4 filed Feb 13, 2023
- 16SEC EDGARForm 4 filed Jan 24, 2023
- 17SEC EDGARForm 4 filed Nov 8, 2022
- 18SEC EDGARForm 4 filed May 11, 2022
- 19SEC EDGARForm 4 filed May 2, 2022